Andrew Combs, Chief Chemistry Officer: Prelude Therapeutics PRLD Buy · Filed 24/12/26

Trade details

Type: Insider buy
Amount: $3,536.25
Shares · price: 3,075 sh · $1.15 a share
Held after: 317,623 sh
Stock: Prelude Therapeutics PRLD
Person: Andrew CombsChief Chemistry Officer
Trade date: 24/12/20
Filed: 24/12/26
Days to filing: 6 days

First buy since 2023

Insiders buying this week: 3 insiders
Holding change: +1.0%

Prelude Therapeutics trades, last 26 weeks

What else happened in Prelude Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/20~25/01/19

Andrew Combs's recent trades

Andrew CombsChief Chemistry Officer
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$69K
100,000 sh
$69K
Filed 25/03/27
Traded 25/03/25
Andrew CombsChief Chemistry Officer
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$82.2K
60,000 sh
$82.2K
Filed 24/12/26
Traded 24/12/23

Andrew Combs, Chief Officer — bought $3,536 of Prelude Therapeutics PRLD · 3,075 sh @ $1.15 | Whalegun